UA817A1 - Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів - Google Patents

Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів

Info

Publication number
UA817A1
UA817A1 UA3646751A UA3646751A UA817A1 UA 817 A1 UA817 A1 UA 817A1 UA 3646751 A UA3646751 A UA 3646751A UA 3646751 A UA3646751 A UA 3646751A UA 817 A1 UA817 A1 UA 817A1
Authority
UA
Ukraine
Prior art keywords
diabicyclic
nonanes
obtaining
substituents
compounds
Prior art date
Application number
UA3646751A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Шьон Уве
Хахмайстер Берг
Кербах Вольфган
Кюль Ульріх
Бушманн Герд
Original Assignee
Калі - Хемі Фарма Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Калі - Хемі Фарма Гмбх filed Critical Калі - Хемі Фарма Гмбх
Publication of UA817A1 publication Critical patent/UA817A1/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Oxide Ceramics (AREA)
UA3646751A 1982-09-18 1983-09-16 Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів UA817A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane

Publications (1)

Publication Number Publication Date
UA817A1 true UA817A1 (uk) 1993-12-15

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
UA3646751A UA817A1 (uk) 1982-09-18 1983-09-16 Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів

Country Status (25)

Country Link
US (2) US4550112A (fi)
EP (2) EP0103833B1 (fi)
JP (2) JPS5970686A (fi)
AT (2) ATE45579T1 (fi)
AU (1) AU564910B2 (fi)
CA (1) CA1254209A (fi)
CS (1) CS389891A3 (fi)
DD (1) DD213923A5 (fi)
DE (3) DE3234697A1 (fi)
DK (1) DK165833C (fi)
ES (1) ES8405398A1 (fi)
FI (1) FI76338C (fi)
GE (1) GEP19960316B (fi)
GR (1) GR78722B (fi)
HU (1) HU191096B (fi)
IE (1) IE57580B1 (fi)
IL (1) IL69751A (fi)
MX (1) MX9202996A (fi)
NO (1) NO160516C (fi)
NZ (1) NZ205627A (fi)
PH (1) PH20768A (fi)
PT (1) PT77344B (fi)
SU (1) SU1272989A3 (fi)
UA (1) UA817A1 (fi)
ZA (1) ZA836185B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
CN1822833A (zh) * 2003-07-21 2006-08-23 索尔瓦药物有限公司 3,7－二氮杂双环[3,3,1]壬烷化合物在治疗和/或预防男性患者心律失常中的用途
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AU2006258293B2 (en) * 2005-06-13 2010-06-17 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (fi) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
AU1920683A (en) 1984-03-22
US4550112A (en) 1985-10-29
FI833339A (fi) 1984-03-19
ZA836185B (en) 1984-04-25
DE3234697A1 (de) 1984-03-22
ATE45579T1 (de) 1989-09-15
ES525653A0 (es) 1984-06-01
DE3382466D1 (de) 1992-01-09
IE832186L (en) 1984-03-18
EP0103833B1 (de) 1989-08-16
GEP19960316B (en) 1996-06-24
PT77344A (en) 1983-10-01
FI833339A0 (fi) 1983-09-19
EP0250903B1 (de) 1991-11-27
US4742172A (en) 1988-05-03
EP0250903A2 (de) 1988-01-07
GR78722B (fi) 1984-10-02
DK422583D0 (da) 1983-09-16
ES8405398A1 (es) 1984-06-01
FI76338C (fi) 1988-10-10
EP0103833A2 (de) 1984-03-28
FI76338B (fi) 1988-06-30
NO160516C (no) 1989-04-26
DK165833B (da) 1993-01-25
PH20768A (en) 1987-04-10
PT77344B (en) 1986-03-11
CA1259998C (fi) 1989-09-26
EP0103833A3 (en) 1984-11-28
ATE69817T1 (de) 1991-12-15
MX9202996A (es) 1992-07-01
JPH05247039A (ja) 1993-09-24
CA1254209A (en) 1989-05-16
SU1272989A3 (ru) 1986-11-23
AU564910B2 (en) 1987-09-03
IL69751A (en) 1986-10-31
JPH0670056B2 (ja) 1994-09-07
NO833346L (no) 1984-03-19
NO160516B (no) 1989-01-16
IL69751A0 (en) 1983-12-30
DE3380409D1 (de) 1989-09-21
JPS5970686A (ja) 1984-04-21
DK422583A (da) 1984-03-19
EP0250903A3 (en) 1988-03-09
HU191096B (en) 1987-01-28
DK165833C (da) 1993-06-21
NZ205627A (en) 1985-11-08
DD213923A5 (de) 1984-09-26
IE57580B1 (en) 1993-01-13
CS389891A3 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
UA817A1 (uk) Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів
SE7906533L (sv) Pyrrolidinderivat
DK173883D0 (da) Substituerede 8-phenylxanthiner
IE792242L (en) Hydroxyazole compounds
GR69296B (fi)
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
FI822099A0 (fi) Maettade aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel
JPS55164676A (en) Novel 3*4*55trihydroxypiperidine compound
ATE67186T1 (de) 3-methylphthalimide.
GR76023B (fi)
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
ES517874A0 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
ES550218A0 (es) Procedimiento para la obtencion de dihidrotiazinas asimetri-cas
ES502033A0 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
MX9101659A (es) Derivados de ergolina, proceso para su produccion y composicion farmaceutica que los contiene.